FEATURED
Janssen applies to FDA for New Indication of XARELTO® for Peripheral Artery Disease
The Janssen Pharmaceutical Companies of Johnson & Johnson revealed on Monday the submission of the supplemental New Drug Application (sNDA)
DEALS
Moderna signs agreement to supply Qatar with mRNA COVID-19 vaccine
American biotech Moderna has signed an agreement with the Ministry of Public Health to supply Qatar with its mRNA COVID-19
PRESS RELEASES
Watlow launches LEGACY SERIES Panel-mount Temperature Controllers
Watlow® has introduced its new LEGACY SERIES Panel-mount Temperature Controllers, which offer simple menus and are perfectly suited for basic
Comments & Analysis
The Acceleration of Digitalisation in Pharma in 2020
This year, more than ever has required the pharma industry to dive into digitalisation in all shapes and forms. With
RESOURCES
Download the latest pharmaceutical case studies, white papers, research papers and product brochures
Advanced ceramic heaters benefits for analytical equipment
How advanced ceramic heaters offer more design flexibility for mass spectrometers and other pieces of analytical equipment A WATLOW White
LATEST PROJECTS
Solid Dose Packaging & Distribution, Aphena Pharma, Tennessee, USA
Aphena Pharma Solutions has announced a $21 million expansion of its Solid Dose Division in Cookeville, Tennessee, United States. The
CLINICAL TRIALS
AstraZeneca receives FDA authorisation to resume COVID-19 vaccine trial
AstraZeneca has confirmed that the U.S. FDA has authorised the resumption of Phase III clinical trials of the COVID-19 AZD1222
REGULATORY
Janssen applies to FDA for New Indication of XARELTO® for Peripheral Artery Disease
The Janssen Pharmaceutical Companies of Johnson & Johnson revealed on Monday the submission of the supplemental New Drug Application (sNDA)
Sponsored by
